Pharmacologic management of chronic constipation

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Chronic constipation is a prevalent gastrointestinal disorder in North America.
• It carries substantial psychosocioeconomic burdens.
• Standard treatments like diet, lifestyle changes, and over-the-counter laxatives are often insufficient, aiding only about 50% of patients.

Purpose of the Study:

• To review the pharmacology of both traditional and novel therapeutic agents for managing chronic constipation.

Main Methods:

• Literature review focusing on the mechanisms of action of constipation pharmacotherapies.
• Analysis of pharmacological properties of established and emerging constipation treatments.

Main Results:

• Traditional laxatives offer limited efficacy for a significant portion of patients.
• Newer agents demonstrate effectiveness by modulating colonic peristalsis, secretion, and enteric opioid receptors.
• These advanced treatments alleviate constipation symptoms and enhance patients' quality of life.

Conclusions:

• Pharmacological interventions are crucial for effective chronic constipation management.
• Novel therapeutic agents provide improved treatment options beyond traditional methods.
• Understanding the pharmacology of these agents is key to optimizing patient outcomes.